Skip to search formSkip to main contentSkip to account menu

LMI1195

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Correction to: PET imaging of sympathetic innervation with [18F]Flubrobenguane vs [11C]mHED in a patient with ischemic cardiomyopathy
At time of initial publication, the USAN Council had assigned the generic name for LMI1195 as Flurobenguan. However, the Council… 
2012
2012
F-18 labeled PET tracer LMI1195 for imaging norepinephrine handling in rat hearts
2012
2012
LMI1195 and flurpiridaz F 18 PET imaging in evaluation of time-course changes in mismatch of cardiac denervated and perfusion defect areas following acute myocardial infarction
2011
2011
Evaluation of LMI 1195 , a Novel 18 F-Labeled Cardiac Neuronal PET Imaging Agent , in Cells and Animal Models
Background—Heart failure has been associated with impaired cardiac sympathetic neuronal function. Cardiac imaging with… 
2011
2011
Roles of cardiac norepinephrine uptake 1 and 2 in evaluation of LMI1195, a new cardiac PET neuronal imaging agent, in rats, rabbits and nonhuman primates
2010
2010
Radiation dosimetry of LMI1195, first-in-human study of a novel F-18 labeled tracer for imaging myocardial innervation
2010
2010
18F PET imaging of cardiac sympathetic denervation with LMI1195, a new neuronal imaging agent
1701 Objectives Cardiac sympathetic denervation (CSD) assessed by 123I-metaiodobenzylguanidin (MIBG) imaging has been suggested… 
2009
2009
Abstract 570: Heart Failure Imaging in the Rat With LMI1195: A New PET Cardiac Neuronal Imaging Agent
LMI1195 is a new 18F-benzylguanidine analog being developed to assess cardiac neuronal function by targeting the norepinephrine… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)